Literature DB >> 2419443

Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions.

J A Warner, M M Pienkowski, M Plaut, P S Norman, L M Lichtenstein.   

Abstract

We have shown that fluids collected from antigen-challenged skin blisters during the late phase reaction cause the release of substantial amounts of histamine (means = 42%, n = 14) from human basophils in vitro. Control fluids collected either during the immediate phase or from an unchallenged blister released less than or equal to 10% histamine from both basophils and lung mast cells. Late phase blister fluids induced low levels of histamine release from human lung cells (means = 11%, n = 4) that were slightly but not significantly greater than levels induced by control blister fluids. The characteristics of basophil release were similar to IgE-mediated stimuli in dose dependence, calcium and temperature requirements, and kinetics. The IgE dependence of the late phase blister fluid was demonstrated by desensitization of the basophils to anti-IgE, which obviated the response to anti-IgE and blister fluid but did not affect a non-IgE-mediated stimulus. Removal of the cell surface IgE with lactic acid also abolished the response to both anti-IgE and late phase blister fluid. Incubation of the "stripped" cells with serum containing IgE myeloma restored the response to anti-IgE but failed to affect response to late phase blister fluid. The characteristics of release obtained with this factor closely resemble those of an IgE-dependent histamine releasing factor from cultured macrophages previously described by our group.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419443

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  IgE-dependent histamine-releasing factors.

Authors:  H A Sampson; S M MacDonald
Journal:  Springer Semin Immunopathol       Date:  1993

Review 3.  The IgE receptor of eosinophils.

Authors:  M Capron; L Prin
Journal:  Springer Semin Immunopathol       Date:  1990

4.  Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

Authors:  E N Charlesworth; A F Hood; N A Soter; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro.

Authors:  R Alam; J A Grant; M A Lett-Brown
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 6.  Late-phase IgE-mediated reactions.

Authors:  R F Lemanske; M Kaliner
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

7.  The effects of overexpression of histamine releasing factor (HRF) in a transgenic mouse model.

Authors:  Yueh-Chiao Yeh; Liping Xie; Jacqueline M Langdon; Allen C Myers; Sun-Young Oh; Zhou Zhu; Susan M Macdonald
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice.

Authors:  H Yokozeki; M-H Wu; K Sumi; K Igawa; Y Miyazaki; I Katayama; K Takeda; S Akira; K Nishioka
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.

Authors:  R Alam; M A Lett-Brown; P A Forsythe; D J Anderson-Walters; C Kenamore; C Kormos; J A Grant
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Dimerization of translationally controlled tumor protein is essential for its cytokine-like activity.

Authors:  Miyoung Kim; Hyun Jung Min; Hee Yeon Won; Heejin Park; Ji-Chul Lee; Heung-Woo Park; Junho Chung; Eun Sook Hwang; Kyunglim Lee
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.